Learn more

MEDAREX INC

Overview
  • Total Patents
    801
  • GoodIP Patent Rank
    240,548
About

MEDAREX INC has a total of 801 patent applications. Its first patent ever was published in 1987. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are SQUIBB & SONS LLC, NOVIMMUNE SA and AMGEN FREMONT INC.

Patent filings per year

Chart showing MEDAREX INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Cardarelli Josephine M 151
#2 Huang Haichun 108
#3 Srinivasan Mohan 94
#4 Gangwar Sanjeev 88
#5 Pan Chin 83
#6 Korman Alan J 76
#7 Deo Yashwant M 70
#8 Graziano Robert 66
#9 King David John 59
#10 Passmore David B 56

Latest patents

Publication Filing date Title
AU2013203437A1 Human anti-B7RP1 neutralizing antibodies
AU2013202283A1 Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl GM1
WO2011037983A1 Cation exchange chromatography
MX2012001665A Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof.
AR072999A1 HUMAN ANTIBODIES THAT JOIN GEN 3 OF LYMPHOCYTARY ACTIVATION (LAG-3) AND THE USES OF THESE
ZA200904846B Chemical linkers and cleavable substrates and conjugates thereof
ZA200904424B Human antibodies that bind CD19 and uses thereof
EP2240204A1 Anti-clta-4 antibodies with reduced blocking of binding of ctla-4 to b7 and uses thereof
US2009162372A1 Fibronectin ed-b antibodies, conjugates thereof, and methods of use
EP2185692A2 Hco32 and hco27 and related examples
US2008299678A1 Methods for characterizing glycosylation sites
AU2008232732A1 Methods of gene amplification and expression
CN101616911A Chemical linkers and conjugate thereof with single amino acids
TW200846365A CD44 antibodies
TW200833713A Human antibodies that bind CD19 and uses thereof
KR20090088946A Human antibodies that bind cd70 and uses thereof
CN101605906A In conjunction with human antibodies of CD70 and uses thereof
SG177168A1 Human antibodies that bind cd22 and uses thereof
EP2097447A2 Human monoclonal antibodies to btla and methods of use
BRPI0717206A2 monoclonal antibody, isolated human, isolated monoclonal antibody, composition, immunoconjugate, bispecific molecule, isolated nucleic acid molecule, expression vector, host cell, transgenic mouse, hybridoma prepared from mouse, method of modulating an immune response in a subject, Method of inhibiting tumor cell growth in a subject, Method of treating an infectious disease in a subject, Method of enhancing immune response to an antigen in a subject, and Method for preparing an anti-beta antibody